Curcumin compound reactivates Epstein–Barr virus, offering safer cancer therapy
A new study reveals how C210, a curcumin derivative, selectively reactivates Epstein–Barr virus to kill cancer cells without infectious risks, ...
A new study reveals how C210, a curcumin derivative, selectively reactivates Epstein–Barr virus to kill cancer cells without infectious risks, ...
A study of fasting and the ketogenic diet reveals a new vulnerability of pancreatic tumors to an existing cancer drug. ...
In a recent review published in Cell Metabolism, researchers present the role of cyclic fasting and fasting-mimicking diets (FMD) in ...
Announcing a new article publication for BIO Integration journal. The tumor microenvironment (TME) has a crucial role in tumor development, ...
What if a single one-dollar dose could cure cancer? A multi-university team of researchers, supported by federal funding, is developing ...
Antiverse Ltd (Antiverse), a biotechnology company developing a computational antibody drug discovery platform, and GlobalBio, Inc. (GlobalBio), an antibody engineering ...
A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of ...
A new study presents a promising treatment method for so-called fusion-driven cancers, which are currently often difficult to cure. These ...
Insilico Medicine ("Insilico"), a clinical-stage end-to-end generative artificial intelligence (AI) drug discovery company, has achieved a significant breakthrough in the ...
A promising new targeted cancer therapy will soon be available to certain patients with advanced pancreatic cancer – from the ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net